Yuichiro Yamamoto

671 total citations
29 papers, 356 citations indexed

About

Yuichiro Yamamoto is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Yuichiro Yamamoto has authored 29 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Yuichiro Yamamoto's work include SARS-CoV-2 and COVID-19 Research (7 papers), Hepatitis B Virus Studies (3 papers) and Extracellular vesicles in disease (3 papers). Yuichiro Yamamoto is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Hepatitis B Virus Studies (3 papers) and Extracellular vesicles in disease (3 papers). Yuichiro Yamamoto collaborates with scholars based in Japan, United States and Spain. Yuichiro Yamamoto's co-authors include Ai Kotani, Masatoshi Kakizaki, Tatehiro Kagawa, Ken Iseri, Masayuki Iyoda, Makoto Watanabe, Takanori Shibata, Gen Yasuda, Keisuke Yatsu and Nobuhito Hirawa and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Yuichiro Yamamoto

27 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuichiro Yamamoto Japan 10 135 87 73 67 58 29 356
Eric G. Ramírez-Salazar Mexico 13 256 1.9× 34 0.4× 37 0.5× 12 0.2× 65 1.1× 25 421
Yujue He China 8 96 0.7× 11 0.1× 83 1.1× 19 0.3× 48 0.8× 14 311
Kazuo Tsubaki Japan 11 228 1.7× 19 0.2× 70 1.0× 22 0.3× 38 0.7× 36 557
Smriti Chaurasia India 11 154 1.1× 54 0.6× 39 0.5× 10 0.1× 49 0.8× 20 416
Davide Testa Italy 4 56 0.4× 56 0.6× 47 0.6× 25 0.4× 11 0.2× 5 278
Jung‐Min Lee South Korea 11 148 1.1× 12 0.1× 123 1.7× 10 0.1× 206 3.6× 37 526
Rosamond Janis United States 11 106 0.8× 30 0.3× 64 0.9× 29 0.4× 42 0.7× 19 404
Hiroshi Matsushita Japan 13 104 0.8× 41 0.5× 109 1.5× 12 0.2× 69 1.2× 22 603
Hanna E. Abboud United States 7 185 1.4× 148 1.7× 34 0.5× 23 0.3× 16 0.3× 11 442
Theresa H. Wirtz Germany 11 92 0.7× 11 0.1× 46 0.6× 25 0.4× 120 2.1× 41 352

Countries citing papers authored by Yuichiro Yamamoto

Since Specialization
Citations

This map shows the geographic impact of Yuichiro Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichiro Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichiro Yamamoto more than expected).

Fields of papers citing papers by Yuichiro Yamamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichiro Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichiro Yamamoto. The network helps show where Yuichiro Yamamoto may publish in the future.

Co-authorship network of co-authors of Yuichiro Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichiro Yamamoto. A scholar is included among the top collaborators of Yuichiro Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichiro Yamamoto. Yuichiro Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Yuichiro & Kohji Noguchi. (2025). Structural Insights into the SARS-CoV-2 Spike Protein and Its Implications for Antibody Resistance. Biomolecules. 15(11). 1489–1489. 1 indexed citations
2.
Yamamoto, Yuichiro, Tetsuya Inoue, Noboru Sugiyama, et al.. (2025). Synergistic activation of bat SARS-like coronaviruses spike protein by elastase and TMPRSS2. Scientific Reports. 15(1). 26469–26469.
3.
Inoue, Tetsuya, Yuichiro Yamamoto, Yoshimi Shimizu, et al.. (2024). Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies. iScience. 27(4). 109363–109363. 6 indexed citations
4.
Shimizu, Yoshimi, Yuichiro Yamamoto, Tetsuya Inoue, et al.. (2022). The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione. Biochemical and Biophysical Research Communications. 597. 30–36. 25 indexed citations
5.
Yamamoto, Yuichiro, Joaquim Carreras, Masatoshi Kakizaki, et al.. (2022). Anti-HBV drug entecavir ameliorates DSS-induced colitis through PD-L1 induction. Pharmacological Research. 179. 105918–105918. 7 indexed citations
6.
Yamamoto, Yuichiro, Tetsuya Inoue, Masayoshi Fukasawa, et al.. (2022). SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing. International Journal of Molecular Sciences. 23(24). 15834–15834. 7 indexed citations
7.
Kakizaki, Masatoshi, Yuichiro Yamamoto, Kazuaki Kameda, et al.. (2021). Human hepatocyte-derived extracellular vesicles attenuate the carbon tetrachloride-induced acute liver injury in mice. Cell Death and Disease. 12(11). 1010–1010. 9 indexed citations
8.
Kawano, Y., Masashi Nagata, Yasunari Mano, et al.. (2021). The antiplatelet effect of mirtazapine is mediated by co-blocking 5-HT2A and α2-adrenergic receptors on platelets: An in vitro human plasma-based study. European Journal of Pharmacology. 917. 174640–174640. 2 indexed citations
9.
Kakizaki, Masatoshi, Yuichiro Yamamoto, Motoyuki Otsuka, et al.. (2020). Extracellular vesicles secreted by HBV-infected cells modulate HBV persistence in hydrodynamic HBV transfection mouse model. Journal of Biological Chemistry. 295(35). 12449–12460. 22 indexed citations
10.
Kotaki, Ryutaro, M. Kawashima, Asuka Yamaguchi, et al.. (2020). Overexpression of miR-669m inhibits erythroblast differentiation. Scientific Reports. 10(1). 13554–13554. 10 indexed citations
11.
Kotaki, Ryutaro, M. Kawashima, Yuichiro Yamamoto, et al.. (2020). Dasatinib exacerbates splenomegaly of mice inoculated with Epstein-Barr virus-infected lymphoblastoid cell lines. Scientific Reports. 10(1). 4355–4355. 9 indexed citations
12.
Iseri, Ken, et al.. (2019). Effects of Denosumab and Alendronate on Bone Health and Vascular Function in Hemodialysis Patients: A Randomized, Controlled Trial. Journal of Bone and Mineral Research. 34(6). 1014–1024. 76 indexed citations
13.
Higuchi, Hiroshi, Hiromichi Matsushita, Takashi Yahata, et al.. (2019). Increased Granulopoiesis in the Bone Marrow following Epstein-Barr Virus Infection. Scientific Reports. 9(1). 13445–13445. 11 indexed citations
14.
Kakizaki, Masatoshi, et al.. (2018). The immunological function of extracellular vesicles in hepatitis B virus-infected hepatocytes. PLoS ONE. 13(12). e0205886–e0205886. 60 indexed citations
15.
Hirawa, Nobuhito, Yuki Okuyama, Megumi Fujita, et al.. (2017). Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure. Clinical and Experimental Nephrology. 21(5). 858–865. 15 indexed citations
16.
Fujiwara, Akira, Nobuhito Hirawa, Megumi Fujita, et al.. (2014). Impaired nitric oxide production and increased blood pressure in systemic heterozygous ATP2B1 null mice. Journal of Hypertension. 32(7). 1415–1423. 21 indexed citations
17.
Fujiwara, Akira, Nobuhito Hirawa, Yusuke Kobayashi, et al.. (2014). Efficacy of cyclosporine combination therapy for new-onset minimal change nephrotic syndrome in adults. Clinical and Experimental Nephrology. 19(2). 240–246. 2 indexed citations
18.
Yasuda, Gen, Keisuke Yatsu, Yuichiro Yamamoto, & Nobuhito Hirawa. (2012). Effects of Carvedilol as Third-Line Add-On Therapy on Blood Pressure and Glucose Metabolism in Type 2 Diabetic Patients with Chronic Renal Disease Stage 3 and Above. Kidney & Blood Pressure Research. 36(1). 131–138. 2 indexed citations
19.
Kobayashi, Mayumi, Nobuhito Hirawa, Satoshi Morita, et al.. (2010). Silent Brain Infarction and Rapid Decline of Kidney Function in Patients With CKD: A Prospective Cohort Study. American Journal of Kidney Diseases. 56(3). 468–476. 32 indexed citations
20.
Furukawa, Hiroshi, Hisakazu Fujita, Yuichiro Yamamoto, et al.. (2002). Identification of a novel gelsolin truncate in the vertical and metastatic phase malignant melanomas. Melanoma Research. 12(6). 523–528. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric G. Ramírez-Salazar Breakdown of academic impact, for papers by Yujue He Breakdown of academic impact, for papers by Kazuo Tsubaki Breakdown of academic impact, for papers by Smriti Chaurasia Breakdown of academic impact, for papers by Davide Testa Breakdown of academic impact, for papers by Jung‐Min Lee Breakdown of academic impact, for papers by Rosamond Janis Breakdown of academic impact, for papers by Hiroshi Matsushita Breakdown of academic impact, for papers by Hanna E. Abboud Breakdown of academic impact, for papers by Theresa H. Wirtz
Rankless by CCL
2026